Halogen Bond: Its Role beyond Drug–Target Binding Affinity for Drug Discovery and Development
2013 · Journal of Chemical Information and Modeling · 415 citations
https://doi.org/10.1021/ci400539q
Z
Zhijian Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
353
Papers
5.5K
Citations
37
h-index
115
i10-index
Zhijian Xu is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Gamma-ray bursts and supernovae & Computational Drug Discovery Methods & Crystallography and molecular interactions. The author has an h-index of 37, co-authored 301 publications.
ORCID: 0000-0002-3063-8473Papers by this author
worksD3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
2020 · Acta Pharmaceutica Sinica B · 87 citations
https://doi.org/10.1016/j.apsb.2020.04.006
Regioselectivity and Mechanism of Synthesizing N-Substituted 2-Pyridones and 2-Substituted Pyridines via Metal-Free C-O and C-N Bond-Cleaving of Oxazoline[3,2-a]pyridiniums
2017 · Scientific Reports · 15 citations
https://doi.org/10.1038/srep41287
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
2020 · Journal of Experimental & Clinical Cancer Research · 14 citations
https://doi.org/10.1186/s13046-020-01597-9
DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway
2017 · Cell Death and Disease · 12 citations
https://doi.org/10.1038/cddis.2017.472
O-GlcNAcylation enhances Reticulon 2 protein stability and its promotive effects on gastric cancer progression
2023 · Cellular Signalling · 12 citations
https://doi.org/10.1016/j.cellsig.2023.110718
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat